After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Haemonetics Corp is listed on the NYSE as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Haemonetics Corp is $3.32B. A total of 1.17 million shares were traded on the day, compared to an average of 859.09K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, HAE has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Lingamneni Anila bought 6,238 shares of HAE for 90.68 per share on Nov 11 ’24. In a previous transaction on Jul 26 ’24, Strong Stewart W sold 4,312 shares at 91.15 per share. HAE shares that President, Global Hospital owns now total 18,196.
Among the insiders who bought shares, Strong Stewart W acquired of 4,312 shares on Jul 26 ’24 at a per-share price of $91.15. In another insider transaction, Lingamneni Anila sold 2,136 shares at $90.00 per share on Jul 11 ’24. Company shares held by the EVP, Chief Technology Officer now total 21,410.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for HAE in the last 3 months, the mean price target is $96.80 with high estimates of $120.00 and low estimates of $68.00. In terms of 52-week highs and lows, HAE has a high of $97.97 and a low of $58.80.
As of this writing, HAE has an earnings estimate of $1.22 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $1.28 per share and a lower estimate of $1.17.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HAE’s latest balance sheet shows that the firm has $259.50M in Cash & Short Term Investments as of fiscal 2022. There were $773.59M in debt and $442.27M in liabilities at the time. Its Book Value Per Share was $18.05, while its Total Shareholder’s Equity was $749.42M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HAE is Buy with a score of 4.33.
